The comparative myocardial protection by propofol and isoflurane in an in vivo model of ischemia reperfusion

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 15, Issue 1-2, 2011, Pages 56-65

  Asgeri, Mehrdad ^a   Ahmadpour, Faraz ^b   Negargar, Sohrab ^a   Khadra, Wiam Z ^a   Porhomayon, Jahan ^a   Nader, Nader D ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Isoflurane; Myocardial ischemia; Preconditioning; propofol; Reperfusion

Indexed keywords

ISOFLURANE; MALONALDEHYDE; MYELOPEROXIDASE; PROPOFOL; TAU PROTEIN; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL RABBIT; HEART ARRHYTHMIA; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE RELAXATION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; INFLAMMATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MORTALITY; NONHUMAN; OXIDATIVE STRESS; REPERFUSION INJURY; TOURNIQUET;

ANIMALS; DISEASE MODELS, ANIMAL; ISOFLURANE; MALONDIALDEHYDE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; PEROXIDASE; PROPOFOL; RABBITS; VENTRICULAR FUNCTION, LEFT;

EID: 80054872355     PISSN: 10892532     EISSN: 19405596     Source Type: Journal    
DOI: 10.1177/1089253211411732     Document Type: Article

References (21)

1. Kevin LG, Katz P, Camara AK, Novalija E, Riess ML, Stowe DF. Anesthetic preconditioning: effects on latency to ischemic injury in isolated hearts. Anesthesiology. 2003;99:385-391. (Pubitemid 36909564)
2. Novalija E, Kevin LG, Eells JT, Henry MM, Stowe DF. Anesthetic preconditioning improves adenosine triphosphate synthesis and reduces reactive oxygen species formation in mitochondria after ischemia by a redox dependent mecha-nism. Anesthesiology. 2003;98:1155-1163. (Pubitemid 36520202)
3. Nader ND, Li CM, Khadra WZ, Reedy R, Panos AL. Anesthetic myocardial protection with sevoflurane. J Cardiothorac Vasc Anesth. 2004;18:269-274. (Pubitemid 38849411)
4. Novalija E, Varadarajan SG, Camara AK, et al. Anesthetic pre-conditioning: triggering role of reactive oxygen and nitrogen species in isolated hearts. Am J Physiol Heart Circ Physiol. 2002;283:H44-H52. (Pubitemid 34705322)
5. Kowalski C, Zahler S, Becker BF, et al. Halothane, isoflurane, and sevoflurane reduce postischemic adhesion of neutrophils in the coronary system. Anesthesiology. 1997;86:188-195. (Pubitemid 27044016)
6. Crystal GJ, Gurevicius J, Salem MR, Zhou X. Role of adenosine triphosphate-sensitive potassium channels in coronary vasodilation by halothane, isoflurane, and enflurane. Anesthesiology. 1997;86:448-458. (Pubitemid 27093389)
7. Ansley DM, Sun J, Visser WA, et al. High dose propofol enhances red cell antioxidant capacity during CPB in humans. Can J Anaesth. 1999;46:641-648. (Pubitemid 29378684)
8. Zhang S, Yao S. Potent antioxidative potential of propofol during cardiopulmonary bypass in the adult. J Tongji Med Univ. 2001;21:349-352. (Pubitemid 41289840)
9. Ansley DM, Xia Z. Propofol preservation of myocardial function in patients undergoing coronary surgery using cardiopulmonary bypass is dose dependent. Anesthesiology. 2003;98:1028.
10. Arya VK, Kumar A, Thingnam SK. Propofol infusion into the pump during cardiopulmonary bypass: is it safe and effective? J Cardiothorac Vasc Anesth. 2004;18: 122-123. (Pubitemid 38240777)
11. Raza SM, Masters RW, Zsigmond EK. Haemodynamic stability with midazolam-ketamine-sufentanil analgesia in cardiac surgical patients. Can J Anaesth. 1989;36:617-623. (Pubitemid 19286186)
12. Zilberstein G, Levy R, Rachinsky M, et al. Ketamine attenu-ates neutrophil activation after cardiopulmonary bypass. Anesth Analg. 2002;95:531-536. (Pubitemid 35006835)
13. Mikawa K, Akamatsu H, Nishina K, et al. Propofol inhibits human neutrophil functions. Anesth Analg. 1998;87: 695-700. (Pubitemid 28397501)
14. Murphy PG, Myers DS, Davies MJ, Webster NR, Jones JG. The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth. 1992;68:613-618.
15. De Hert SG, Turani F, Mathur S, Stowe DF. Cardioprotection with volatile anesthetics: mechanisms and clinical implica-tions. Anesth Analg. 2005;100:1584-1593. (Pubitemid 40712704)
16. Tatarková Z, Aplán P, Matejovicová M, Lehotský J, Dobrota D, Flameng W. Effect of ischemia and reperfusion on protein oxi-dation in isolated rabbit hearts. Physiol Res. 2005;54:185-191. (Pubitemid 40686265)
17. + concentration in car-diac muscle cells. Adv Exp Med Biol . 1991;301:125-141.
18. De Hert SG, Cromheecke S, ten Broecke PW, et al. Effects of propofol, desflurane, and sevoflurane on recovery of myocar-dial function after coronary surgery in elderly high-risk patients. Anesthesiology. 2003;99:314-323. (Pubitemid 36909557)
19. Zhong C, Zhou Y, Liu H. Nuclear factor kappaB and anesthetic preconditioning during myocardial ischemia-reperfusion. Anesthesiology. 2004;100:540-546. (Pubitemid 38268870)
20. Stowe DF, Kevin LG. Cardiac preconditioning by volatile anesthetic agents: a defining role for altered mitochondrial bioenergetics. Antioxid Redox Signal. 2004;6:439-448. (Pubitemid 38332602)
21. Novalija E, Kevin LG, Camara AK, Bosnjak ZJ, Kampine JP, Stowe DF. Reactive oxygen species precede the epsilon iso-form of protein kinase C in the anesthetic preconditioning signaling cascade. Anesthesiology. 2003;99: 421-428. (Pubitemid 36909568)